Game Plan Financial Advisors’s Zomedica Corp. ZOM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,000
Closed -$438 438
2024
Q1
$438 Sell
3,000
-500
-14% -$70 ﹤0.01% 387
2023
Q4
$700 Buy
+3,500
New +$615 ﹤0.01% 380
2022
Q4
$5.79K Sell
35,500
-54,500
-61% -$11.2K ﹤0.01% 85
2022
Q3
$19K Sell
90,000
-35,000
-28% -$9.26K 0.02% 86
2022
Q2
$27K Buy
125,000
+20,000
+19% +$5.09K 0.02% 91
2022
Q1
$35K Hold
105,000
0.02% 101
2021
Q4
$32K Sell
105,000
-120,000
-53% -$54K 0.02% 106
2021
Q3
$118K Buy
225,000
+211,500
+1,567% +$125K 0.07% 95
2021
Q2
$11K Buy
+13,500
New +$12.6K 0.01% 103

Other funds holding ZOM

Game Plan Financial Advisors's ZOM Position: Q2 2024 in Review

Game Plan Financial Advisors sold out of Zomedica Corp. (ZOM) in Q2 2024, closing a stake of 3,000 shares — an estimated $438 sold.

Game Plan Financial Advisors first reported a position in ZOM in Q2 2021 and held it in 9 quarters. The position peaked at $118K in Q3 2021. 96 funds tracked by Wall St. Rank hold ZOM as of Q2 2024.

  • Game Plan Financial Advisors reported no remaining Zomedica Corp. position as of Q2 2024 after selling out during the quarter.
  • Game Plan Financial Advisors sold 3,000 Zomedica Corp. shares in Q2 2024, an estimated $438.
  • Game Plan Financial Advisors first reported a position in Zomedica Corp. in Q2 2021 and held it in 9 quarters.
  • Game Plan Financial Advisors's Zomedica Corp. position peaked at $118K in Q3 2021.
  • 96 funds tracked by Wall St. Rank held Zomedica Corp. as of Q2 2024.

Based on Game Plan Financial Advisors's 13F filing for Q2 2024, filed 1 Aug 2024.